#VisualAbstract: Three Cycles of Chemotherapy was Noninfererior to Six Cycles for High-Risk Retinoblastoma
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. 3-year invasive disease-free survival among the PET-based treatment group was 94.8%. 2. There were fewer treatment-related and serious adverse ...
1. Progression-free survival was 4.1 months in the combination arm vs 2.2 months in the monotherapy arm with an HR ...
Click to read this study in JAMA Otolaryngology - Head & Neck Surgery.
Click to read this study in Clinical Cancer Research.
Click to read this study in The Lancet Oncology.
Click to read this study in JAMA Network Open.
Click to read this study in the Journal of Clinical Oncology.
1. A randomized controlled trial of patients with stage II and III rectal cancer found that adding oxaliplatin to the ...
Click to read the study in the Journal of Clinical Oncology.
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.